U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents
By Blake BrittainWASHINGTON, Nov 4 (Reuters) - The U.S. Supreme Court on Friday agreed to hear Amgen Inc's bid to revive patents on its cholesterol drug...
By Blake BrittainWASHINGTON, Nov 4 (Reuters) - The U.S. Supreme Court on Friday agreed to hear Amgen Inc's bid to revive patents on its cholesterol drug...